Clinical Trial Update: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial results update evaluating oral minocycline for geographic atrophy in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2024-02-01